Home › Funds › MPM BioImpact LLC › ORKA
MPM BioImpact LLC position in ORKA
ORUKA THERAPEUTICS INC · Health Care
MPM BioImpact LLC reported holding 300,000 shares of ORKA (ORUKA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$25.0M, representing 1.92% of its reported portfolio and ranking #25 among its reported holdings. MPM BioImpact LLC first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How MPM BioImpact LLC's ORKA position evolved
MPM BioImpact LLC first disclosed a stake in ORKA in Q3 2026 at 300,000 shares (US$25.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 300.00K | $24.99M | New |
About ORKA and 13F data
ORKA (ORUKA THERAPEUTICS INC) is a Health Care company. 73 other funds we track also report a position in ORKA — the largest reported positions include Venrock Adviser, LLC (US$345.5M), Fairmount Funds Management LLC (US$308.6M), RTW INVESTMENTS, LP (US$261.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ORKA
- Venrock Adviser, LLC 4.15M sh · $345.52M · Q3 2026
- Fairmount Funds Management LLC 3.71M sh · $308.61M · Q3 2026
- RTW INVESTMENTS, LP 3.14M sh · $261.45M · Q3 2026
- Paradigm Biocapital Advisors LP 2.49M sh · $207.68M · Q3 2026
- Bellevue Group AG 1.64M sh · $136.68M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 1.55M sh · $129.48M · Q3 2026
- PERCEPTIVE ADVISORS LLC 1.07M sh · $89.32M · Q3 2026
- Deep Track Capital, LP 1.07M sh · $89.10M · Q3 2026
- Remedium Capital Partners, LLC 954.15K sh · $79.47M · Q3 2026
- Avidity Partners Management LP 785.42K sh · $65.42M · Q3 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 723.92K sh · $60.30M · Q3 2026
- Affinity Asset Advisors, LLC 600.00K sh · $49.97M · Q3 2026
More on MPM BioImpact LLC
FAQ
How long has MPM BioImpact LLC held ORKA?
MPM BioImpact LLC has disclosed ORKA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is MPM BioImpact LLC's current position in ORKA?
As of Q3 2026, MPM BioImpact LLC holds 300.00K shares of ORKA (ORUKA THERAPEUTICS INC), valued at $24.99M, representing 1.92% of its reported portfolio and ranking #25.
Has MPM BioImpact LLC been buying or selling ORKA?
In the latest 13F filing (Q3 2026), MPM BioImpact LLC newly opened its position in ORKA.
Which other funds hold ORKA?
Other major institutional holders of ORKA include Venrock Adviser, LLC, Fairmount Funds Management LLC, RTW INVESTMENTS, LP, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.